Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Summit Therapeu ADR
(NQ:
SMMT
)
8.390
+0.300 (+3.71%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 14, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Summit Therapeu ADR
< Previous
1
2
3
4
5
6
7
8
Next >
Acurx Pharmaceuticals Stands As Front-Line CDI Treatment Contender After Pfizer Misses Primary Endpoint In CDI Drug Trial (NASDAQ: ACXP)
March 28, 2022
Via
AB Newswire
Exposures
Product Safety
Analyzing Summit Therapeutics Inc's Short Interest
March 21, 2022
Summit Therapeutics Inc's (NASDAQ:SMMT) short percent of float has risen 50.18% since its last report. The company recently reported that it has 1.06 million shares sold short,...
Via
Benzinga
Acurx Pharmaceuticals Ibezapolstat Targets Front-Line Opportunity After Pfizer Fails To Reach CDI Trial Primary Endpoint (NASDAQ: ACXP)
March 07, 2022
Via
AB Newswire
12 Health Care Stocks Moving In Tuesday's After-Market Session
March 01, 2022
Gainers Organogenesis Holdings (NASDAQ:ORGO
Via
Benzinga
80 Biggest Movers From Yesterday
March 02, 2022
Gainers Avenue Therapeutics, Inc. (NASDAQ: ATXI) jumped 78.5% to close at $0.6066 on Tuesday after jumping 36% on Monday. CTI BioPharma Corp. (NASDAQ: CTIC) surged 63...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
January 26, 2022
Gainers Vaccinex (NASDAQ:VCNX) shares moved upwards by 30.4% to $1.33 during Wednesday's pre-market session. The market value of their outstanding shares is at $40.9...
Via
Benzinga
88 Biggest Movers From Yesterday
February 25, 2022
Gainers Cyren Ltd. (NASDAQ: CYRN) shares surged 118.9% to settle at $4.75 on Thursday. Cyren recently announced a $12 million private placement. Indonesia Energy Corporation...
Via
Benzinga
Acurx Pharmaceuticals’ Ibezapolstat Takes Center Stage After Summit Therapeutics Misses Phase 3 C.Diff Trial Endpoints (NASDAQ: ACXP)
January 03, 2022
Via
AB Newswire
INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in Summit Therapeutics Inc. with Losses of $100,000 to Contact the Firm
December 28, 2021
From
The Schall Law Firm
Via
Business Wire
Mid-Afternoon Market Update: Dow Tumbles 500 Points; Bluerock Residential Growth Shares Spike Higher
December 20, 2021
Toward the end of trading Monday, the Dow traded down 1.42% to 34,862.49 while the NASDAQ fell 1.38% to 14,960.51. The S&P also fell, dropping 1.34% to 4,558.87. The U.S. has...
Via
Benzinga
Summit Therapeutics' Infection Candidate Flunks In Head-To-Head Trial
December 20, 2021
Summit Therapeutics Inc (NASDAQ: SMMT) shares are trading lower after disappointing results from the Phase 3 Ri-CoDIFy study of ridinilazole for C. difficile...
Via
Benzinga
65 Biggest Movers From Yesterday
December 21, 2021
Gainers Society Pass Incorporated (NASDAQ: SOPA) shares climbed 240.2% to close at $11.26 on Monday after the company reported addition to the Russell 2000 Index. Bluerock...
Via
Benzinga
Selloff Deepens as Covid-19 Casts Shadow Over Holidays
December 20, 2021
This morning's selloff has deepened by midday, as investors assess how the rapidly spreading Covid-19 omicron variant could impact the holiday season.
Via
Talk Markets
Mid-Day Market Update: Crude Oil Drops Over 5%; Society Pass Shares Jump
December 20, 2021
Midway through trading Monday, the Dow traded down 1.78% to 34,735.33 while the NASDAQ fell 1.43% to 14,952.69. The S&P also fell, dropping 1.59% to 4,547.26. The U.S. has the...
Via
Benzinga
38 Stocks Moving In Monday's Mid-Day Session
December 20, 2021
Gainers Society Pass Incorporated (NASDAQ: SOPA) shares jumped 120.9% to $7.31 after the company reported addition to the Russell 2000 Index. Can-Fite BioPharma Ltd. (NYSE: CANF...
Via
Benzinga
Mid-Morning Market Update: Markets Open Lower; Carnival Reports Downbeat Q4 Revenue
December 20, 2021
Following the market opening Monday, the Dow traded down 1.58% to 34,806.55 while the NASDAQ fell 1.40% to 14,956.74. The S&P also fell, dropping 1.40% to 4,555.91. The U.S....
Via
Benzinga
AcurX Pharmaceuticals’ C. Difficile Drug Candidate Could Fetch $800 Million On A Peer Comparison Basis (NASDAQ: ACXP)
October 20, 2021
Via
AB Newswire
Exposures
Product Safety
50 Biggest Movers From Yesterday
September 23, 2021
Gainers Marin Software Incorporated (NASDAQ: MRIN) shares jumped 61.9% to close at $9.21 on Wednesday following an announcement from management that the company entered into a...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
September 22, 2021
Gainers Regencell Bioscience (NASDAQ:
Via
Benzinga
Mid-Afternoon Market Update: Dow Surges Over 400 Points; Stitch Fix Shares Spike Higher
September 22, 2021
Toward the end of trading Wednesday, the Dow traded up 1.28% to 34,353.01 while the NASDAQ rose 1.07% to 14,904.89. The S&P also rose, gaining 1.15% to 4,404.34. The U.S. has...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
32 Stocks Moving In Wednesday's Mid-Day Session
September 22, 2021
Gainers Marin Software Incorporated (NASDAQ: MRIN) shares climbed 53.1% to $8.71 following an announcement from management that the company entered into a revenue share...
Via
Benzinga
Mid-Morning Market Update: Markets Open Higher; General Mills Reports Upbeat Q1 Results
September 22, 2021
Following the market opening Wednesday, the Dow traded up 1.01% to 34,262.50 while the NASDAQ rose 0.63% to 14,839.63. The S&P also rose, gaining 0.82% to 4,389.97. The U.S....
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
September 22, 2021
Gainers Aethlon Medical (NASDAQ:AEMD) shares rose 33.15% to $5.06 during Wednesday's pre-market session. The market value of their outstanding shares is at $77.8...
Via
Benzinga
The Daily Biotech Pulse: Pfizer-BioNTech US Vaccine Contract, Summit Slumps On Adverse Regulatory Feedback, Cerevel CFO Departs
September 22, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 20) Acceleron Pharma Inc. (...
Via
Benzinga
FDA Not In Favor Of Summit Therapeutics' Endpoint Change To Pivotal Infection Trials
September 22, 2021
Summit Therapeutics Inc (NASDAQ: SMMT) announced that the FDA disagrees with its proposed change to the primary endpoint in Phase 3 Ri-CoDIFy studies. In a regulatory...
Via
Benzinga
Exposures
Product Safety
50 Biggest Movers From Yesterday
May 20, 2021
Gainers MoSys, Inc. (NASDAQ: MOSY) shares jumped 44.1% to settle at $5.46 on Wednesday. Lianluo Smart Limited (NASDAQ: LLIT) gained 24.6% to settle at $9.22. Reata...
Via
Benzinga
35 Stocks Moving In Wednesday's Mid-Day Session
May 19, 2021
Gainers Advaxis, Inc. (NASDAQ: ADXS) shares jumped 43.1% to $0.6943 after jumping over 14% on Tuesday. MoSys, Inc. (NASDAQ: MOSY) shares gained 32% to $5.00. Reata...
Via
Benzinga
58 Biggest Movers From Yesterday
May 19, 2021
Gainers BM Technologies, Inc. (NYSE: BMTX) shares climbed 26.4% to close at $11.82 on Tuesday after the company reported record Q1 results. Ultralife Corporation (NASDAQ: ULBI)...
Via
Benzinga
Summit Therapeutics Stock Surges Higher But Slams Into A Wall Of Resistance
May 18, 2021
Shares of Summit Therapeutics Inc. (NASDAQ:SMMT) stock had...
Via
Benzinga
Summit Therapeutics Unveils Preclinical Candidate For Multidrug-Resistant Infections
May 18, 2021
Summit Therapeutics Inc (NASDAQ: SMMT) has selected a new preclinical candidate, SMT026738 (SMT-738), for development against multidrug-resistant infections,...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.